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Superantigens are potent modulators of the immune 
system, especially T cells. Therefore, we determined 
the influence of superantigens on the T -cell-medi-
ated immune response, contact sensitivity. We chose 
the combination of staphylococcal enterotoxin B 
(SEB) as superantigen and 2,4-dinitrofluorbenzene 
(DNFB) as the contact sensitizer, because in BALB/c 
mice SEB reacts almost exclusively with V/38+ T cells, 
and these cells are capable of transferring contact 
sensitivity to DNFB from sensitized donors to naive 
syngeneic recipients. Pretreatment with a single in-
tradermal injection of 50 ng SEB 24 h before DNFB 
exposure at the same site on the lower abdomen 
enhanced the induction of contact sensitivity: its 
intradermal injec#on permitted sensitization with 
C ontact. allergic responses as a manifestation .of. de-layed-type hypersensitivity arc mediated by T cell s [1,2]. During th e induction phase, antigen/hapten-specific T cells are induced by appropriate presen-tation of the hapten in the context of major histo-
compatibility co mplex (MHC) class II molecules. Inappropriate 
presentation, however, leads to anergy and tolerance due to the 
lack or presence of soluble or m embrane-bound factors [3,4]. 
Stimulation ofT cells can also occur in the presence of superan ti-
gens that bind to the V {3-region of the af3 T -cell receptor [5,6] and 
to MHC-class TI molecules outside the regular antigen binding 
groove [7 ,8]. This interaction can .l ead to activation, cytokine 
production, and proliferation or to anergy and deletion of the 
responsive Vf3 T-cell subsets [9-1.7]. In view of i ts broad effects on 
T-ccU responses, we evalu ated the effect of a superantigen on the 
development of contact sensitivity. Because of potential clinical 
significance, we chose a bacterial superantigen derived from bac-
teria that colonize the skin in various disease conditio n s, as such 
supcrantigenic products may very well influence contact dermatitis 
reactions in a clinical setting [18, 19] . 
Staphylococcal enterotoxins (SE) have been sh own by other 
investigators to suppress delayed-type hypersensitivity - ~~sponses as 
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non-sensitizing concentrations of DNFB as assessed 
by ear swelling responses after challenge with DNFB. 
In contrast, pretreatment with repeated intradermal 
injections of 50 ng SEB every other day over at least 1 
week inhibited the induction of contact sensitivity fol-
lowing sensitization. The enhancing effect of SEB may 
be explained by the creation of a proinflammatory 
milieu in the skin after a single intradermal injection o£ 
the bacterial toxin, whereas the inhibitory effect may be 
due to tolerization of V/38+ T cells. The data indicate 
that products of skin-colonizing bacteria that can serve 
as superantigens are able to augment or inhibit the 
developement of contact sensitivity. Key words: cor1tact 
settsitivity!Sitperatttigert!staphylococcal et~terotoxirt B/2,4-ditti-
tro.fluorbenzet~e. J l1west Dermatol 105:220-224, 1995 
well as other immune reactions in IJiiJo [20 -23] , but true contact 
sen sitivity was not investigated in these studies. Inhibition of 
contact sensitivity to 2,4-dinitroAu o rbenzene (DNFB) has been 
desc1·ibed in only one investigation using C57BL/6 mice utilizing 
SEA as a superantigen [24], but no analys is ofVf3 T-cell populations 
was included in tlus study. 
In tl1e present study we chose the combination of DNFB and 
SEB, as contact sensitivity to DNFB is a well-characterized model, 
and Vf38 + T ce Lls are capab le of transferring contact sensitivity to 
thjs hapten in BALB/c mice. In BALB/c mice Vf38+ T cells 
represent a large T -cell population and are the primary responders 
to SEB [7]. 
MATEIUALS AND METHODS 
Experimental Animals Female BALB/c mice Qackson Laboratories, 
Bar Harbor, M:E) of about 10 weeks of age and majntained under approved 
instimtional guidelines were used in all experiments. T hese mjce lack Vf33-
and V{317-positive T cell s. Therefore V{37 (small fraction) and V{38 (m,\ior 
proportion) serve as the SEE-reactive T cells (7]. 
Contact Sensitization Unless otherwise indicated the lower abdomen 
was shaved with an electric clipper and pajnted on two consecutive days 
with 30 J.Ll of DNFB (Sigma, St. Louis, MO) dissolved in oil/acetone 
(mixture of 1:4 parts) at a concentration of 0.5'Yu. Control animals were 
painted with the solvent oil/acetone alone. 
Testing for Contact Sensitivity After measurement of the baseline 
thickness of both ears, 30 J.LI of DNF.B 0.2'!1,, dissolved in oil/acetone 
(mixture of l :4 parts), was applied onto the dorsum of both ears, and ear 
thickness was measured with a modified micrometer 24 h later. The car 
swelling response was calculated by subtracting the thickness prior to testing 
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from th e thickness observed 24 h after tl!sti ng. Contro l testing was 
performed with the so lvent (oil/acetone) alone. 
Pretreatment Fifty nanograms of staphylococcal enterotoxin B (SEB, 
Toxin Technology. Saraso ta , FL) or alternatively (where indicated) 1 ng of 
SEA (Toxin Techno logy), which is about 1. 00 times more potem a 
supcr:mtigen than SEB, was injected into the skin of the abdomen either 
once or repeatedly as described in R cs11/ts. Contro l animals were injected 
o nly with the solvent PBS. 
Transfer T he eel.! preparations were suspended in one ml of PBS and 
injected i11 to the tail ve in of naive syngeneic recipients with a tubercu lin 
syringe and a 26-gaugc needle. 
Cell Preparation In all experimen ts, local draining lymph node (LN) 
cell s were used and prepared by removing the inguinal LN under sterile 
conditions and dispersing them mechanical.l y through stainless steel mesh 
screens to provide single cell suspensions. 
Separation ofV/38+ T cells Tissue culture flasks were directly coated with 
h ybridoma culture supernatants of monoclonal V{38-antibody (F23.1, kindly 
provided by Drs.]. Kappler and P. Manack, Denver, CO) at 4°C overnight. 
Afterwards the antibody supernatant was removed and the flasks were washed 
with tissue culture medium. Suspensions from the lymph nodes were then 
added and incubated at 37°C in S'X, C02 . Mtcr 2 h the flasks were gently 
washed with prewanned medium (37°C) to remove unbound cel.ls, and tissue 
culture medium containing intcrl eukin 2 (Ilr-2, obtained f:i:om the Biological 
Response Modifi er l'rot,>Tam, NC) at a concentration of 50 U/ ml was added, 
and retained cells were incubated at 37°C in 5% C0 2 • After 3 d the cells were 
harvested, extensively washed, and transferred in to recipients. An aliquot was 
checked for purity by fl ow cytometry (> 98% V{38 +). 
Flow Cytometry For cell staining, cel.ls were placed in 96-wel.l micro-
titer plates and washed with staining bufFer (PBS supplemented \vitb 2% 
heat-inactivated fetal bovine serum (FBS) and 0. 1% sodium azide) . 20 J.LI of 
1:10 diluted mouse se rum was added for blocking of nonspecific binding 
si tes followed by 20 J.Ll of biotiJ1ylated V {3-antibody (kindly provided by 
Drs. J. Kappler and P. Marrrack) diluted in staining buffer. T he incubation 
w as carried out on icc for 30 min . After washing, 20 J.LI of diluted 
PE-streptavidin (Tago, Burlingame, CA) was added to tl1e wells. For CD3 
staining 20 J.L) of directly FITC-labeled antibody (kindly provided by Drs.]. 
Kappler and P. Marrack) diluted in staining buffer was added. T lus second 
incubation was ca rri ed o ut for 30 min on icc in tl1e dark. After washing, cell 
pellets were resuspended in staining buffer and examined with an EPI CS 
ana lyze r (Coul ter Electronics, Hialeah , FL) . 
Tissue Culture C ul ture medium consisted of Iu>MJ 1640 (Gibco, Grand 
Island, NY) witl1 L-glu tamine (2 mM) , pcnicilliJl (1 00 U / ml), streptomycin 
(100 J.Lglml), 2-mcrcaptocthanol (SmM). H.EPES buffer ( IS mM), N a-
pyruvate (1mM) and FBS (10% H yclone, Logan, UT). Conditions were 
3 7°C and 5% C02 . 
Proliferation Assay LN cell s were incuba ted in tripli cate wells fo r 72 h 
in fl at-bottom culture plates containing 200,000 ce ll s per well SEB was 
added at a fina l concentration ofl J.Lg/ml and Con A at a fin al concentration 
of 5 J.Lg/ml. Pro li feration was assessed by incorporation of I"' H) thymidine 
added at a concentration of 1 J.LCi (6.7 C i/ mM, IC N, Irvine, CA) to each 
well 6 h before harvesting . 
Intcrfcron-1' Assay IFN-1' was measured in culture supernatants with an 
EUSA-f{jt (Gcnzyme, Cambridge, MA) according to tllC manuf.1crurer 's 
instructions. Cell-lice supernatants were collected from 48-h cultures of 
single-cell suspensions from inguinal lymph nodes of differently pretreated 
animals incubated with medium alone o r with SEB at a concentration of 
l J.Lg/ml. 
Statistics Al l resul ts arc depicted as mean ::':: SO. Student two-tailed 
unpaired t test was used to detcnnine the level of d ifference (p) between 
two groups. 
RESULTS 
Determination of Sensitizing and Non-Sensitizing Protocols 
for DNFB Exposure Protocols that lead to the induction of contact 
sen sitivity to DNFB are well established [4]. As expected , painting of 
the shaved abdomen vvith 30 fLl of0.5% DNFB in oil/acetone on two 
consecu tive days led to the induction of contact sensitivity as assessed 
b y positive ear swelling responses m easured 24 h after application of20 
fLl of0.2% DNFB on the ears . Control animals that had been painted 
w ith oil/acetone only did not exhibit significant ear swelling responses 
a fte r challenge with 0 .2% DNFB on their ea!"s (data not shown) . 
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Fig ure 1. Transfer of contact sensitivity to DNFB by V/38+ T cells. 
One group of donor BALB/c mice was sensitized to DNFB by painting of 
the abdominal skin with DNFB 0.5% in o ilhlcetone on two occasions (over 
2 d). A contro l group was exposed to the so lvent alone. After three 
additiona l days regional drain ing LN cells were prepared. V{38 + T cel.ls were 
purified by pamung and expa.ndcd with IL-2 for 3 d. Cells were washed. 
purity was checked by flow cytomctry (> 98o;., V/38 + T cells), and cells were 
transferred intravenously inro naive syngeneic recipients. Recipients were 
c!w llcnged after one additiona l da y with DNFB 0.2% to the ears and car 
swelLing responses were recorded 24 h later. T he res ul ts arc given as mean 
::':: SO of two independent experiments with three animals in each group of 
recipients. *Signif:i candy increased car swelling responses (p < 0.05) compared 
to all g roups of recipients of ce lls from non-sensitized donors. 
Paintin g of the abdomen o n two consecutive days with 0.2% DNFB 
followe d by cal" challenge vvith 0.2'Yo DNFB also tailed to induce ca1· 
sw e lling responses, indica ting that contact sensitization did n ot take 
place in these mice (data not shown). 
Vf38 + T cells Mediate Contact Sensitivity to DNFB To 
investiga te whed1er V{38 T cells are able to m ediate contact sensi-
ti v ity to DNFB, donor mice were sen sitized to DNFB by p ainting the 
shaved abdomina.l skin vvith 30 fLl of DNFB 0.5% in oil/ acetone on 
two consecutive days. After tlu·ee d ays the m.ice were sacrificed and 
cells fi·om the regional draining (ing uinal) L N were isolated . Vf38 + T 
cells were positively selected b y direct pmU1ing and c ll:panded with 
interlcuk.in-2 for d1r ce days. B efore transfer into naive syngen eic 
recipients, cells were washed extensively and pm~ty was confu111cd by 
flow cytom etry (> 98% V/38 +) . On th e d ay fo llowing transfer , recip-
ients were teste d for contact sensitivity b y car challen ge wid1 DNFB 
0.2% in oil /acetone an d m easurem ents of ear swelling response 24 h 
after ch allen ge. V/38 + T cells from DNFB-sensitizcd donors were able 
to transfer contact sen sitivity to DNFB in a dose-dependent manner. 
At least 12.5 X 10r. Vf38 + cells fi·om DNFB-scnsitized donors were 
needed to induce significant (p < 0.05) increases in ear swelling 
respo n ses after challenge vvith DNFB compared to con trol recipients 
(sec b e low) (Fig 1). Follovving tran sfer of25 X 10r. Vf38 + T cell s liom 
D.NFB-sen sitized mice, increases in ear swelling responses after chal-
len ge with DNFB reach ed a pla teau (Fig 1). T ransfer of T cells 
d epleted ofV{38 + cells from DNFB-sensitized d onors were 5-10 times 
less ef!:i cient thm1 V/38 + T cells (data not shownf Control recipients 
tl1at were chal.lcnged in the san1e way and tl1at had received Vf38 + T 
cells pUJi.fied and expanded in the sam e way fi:om control donors 
treated with oil/acetone alone did not exhibit an y significant ear 
swelling respo n ses after challen ge with DNFB (Fig 1). 
Pretreatment With a Single Intradermal Injection of a 
Small Amount of SEB Enhances Induction of Contact 
Sensitivity to DNFB A single in tr a d erm al injection of S.EB has 
pre viously b een sh own to induce a strong inflammatory response in 
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Figure 2. Augmentation of induction of contact sensitivity to 
DNFB following a single intracutaneous injection of SEB. One 
group of mice was injected with SEB (50 ng intradermally) in the lower 
abdomen, and a control group was injected with PBS alone. Twenty-fou.r 
hours later. half of the mice were exposed to a low concentration ofDNFB 
(0 .2% in oil/acetone) and the other half to the solvent oil/acetone at the 
same sites where SEB had been injected before. After 3 additional days all 
mice were challenged with DNFB 0.2% to the ears, and car swelling 
responses were recorded after 24 h. The results arc given as mean ::!:: SO of 
three independent experiments with three mice in each subgroup. *Signifi-
cantly increased ear swelling response (p < 0.05) compared to aU other 
subgroups. 
the skin at the injected site.:j: To investigate the consequences of 
tlus proinflammatory effec t of SEB in the skin on the induction of 
contact sensitivity to DNFB, we injected 50 ng of SEB intrader-
mally into the shaved abdomen. On the fo llowing two days tl~e skin 
was painted with DNFB 0.2% in oil/acetone at the same site. Mter 
three additional days the mice were tested for contact sensitivity to 
DNFB by ear challenge with DNFB 0.2% in oil/acetone and 
m e asurement of ear swelling responses 24 h later. 
Mice pretreated by a single SEE-injection were sensitized by 
these low concentrations of DNFB, as they exhibited significant 
(p < 0.05) ear swelling responses after challenge with DNFB 
compared to control animals that had been pretreated with SEB, 
treated with oil/acetone alone, and challenged with DNFB in the 
same way (Fig 2). Mice pre treated with PBS only were not 
sensitized to DNFB by prunting with 0.2% DNFB, as they did not 
exhibit increased ear swelling responses after challenge with DNFB 
(Fig 2). Tlus indicates that although sensitization with DNFB 0.2% 
is not able to induce contact sensitivity to DNFB on its own, 
pretreatm ent with SEB converts a nonsensitizing dose to a sensi-
tizing one. This augmenting effect was not lOJ1g lasting. as it was not 
observed when mice were painted with DNFB one week after SEB 
pretreatment. 
Pretreatment With Repeated Intradermal Injections of 
Small Amounts of SEB Inhibits Induction of Contact Sen-
sitivity to DNFB As SEB can down regulate and induce deletion 
of V(38 + T cells under certain conditions [9-15], we investigated 
tbe effects of repeated SEB treatment on the induction of contact 
sensitivity to DNFB. For tlus purpose mice were injected with 50 
ng SEB into the shaved skin of the abdomen every other day over 
a p e riod of 1 to 2 weeks. Mice in each group were then exposed to 
30 J..tl of DNFB 0.5% in oil/acetone at the same site on two 
:j:Saloga J, Rcnz H. Leung DYM, Gelfand EW: Superantigens derived 
from skin colonizing staphylococci profoundly influence immunological 
reactions of the skin (abstr). J II west Denuat:o/1 01:406. 1993 . 
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Figure 3. Inhibition of contact sensitivity to DNFB by repeated 
intradermal injections of SEB. Groups of mice were injected intrader-
mally with SEB (50 ng in PBS) or PBS on the lower abdomen every other 
day for one week, and the other group was injected similarly for two weeks. 
All mice were then painted wiili DNFB (0 .5% in oil/acetone) on two 
consecutive days on the abdomen at tl1e site of the injections. Following an 
additional 3 d, all mice were challenged with DNFB 0.2% to the ears, and 
the car swelling responses were recorded after 24 h. The results are given as 
mean :!:: SD of three independent experiments witl1 three mice in each 
subgroup. *Significantly lower ear swelling responses compared to the PBS 
pretreated subgroups (p < 0.05). 
consecutive days. Mter an additional 3 d, contact senstt:JvJty to 
DNFB was tested by ear challenge with DNFB 0.2% in oil/acetone 
and with measurement of ear swelling 24 h later. Alumals pre-
treated with SEB injections for 1 week (or to a greater extent, if 
pretreated for 2 weeks) exlubited sigtuficantly (p < 0.05) decreased 
ear swelling responses after challenge with DNFB compared to 
PBS-pretreated control animals (Fig 3). Allimals that were pre-
treated with an equ ipotent dose of a superantigen that does not 
affect V{38 + T cells (i .e., 1 ng of SEA [7) instead of 50 ng of SEB) 
but were otherwise treated in the same way as SEB pretreated mice 
were sensitized normally to DNFB (data not shown). These data 
indicate that repeated injections of SEB do not enhance but rather 
inhibit the development of contact sensitivity to DNFB. If nuce 
were sensitized to DNFB after a period of two months following 
SEB injections, they exhibited normal ear swelling responses (data 
not shown), indicating that the inhibitory. effect was not permanent. 
Repeated Injections ofSEB Do Not Lead to Deletion But to 
Functional Down-Regulation of V/38+ T cells in the Skin 
Associated Lymphoid Tissue (SALT) To investigate the un-
derlying m echanism responsible for the inlubitory effects of chronic 
SEB exposure on the induction of contact sensitivity to DNFB, we 
analyzed the mrun cell target of SEB in BALB/c mice, V(38 + T 
cells. V{314 + T cells, which do not react with SEB [7], were 
monitored in parallel. One week after repeated SEB exposure, the 
frequency of V{38 + T cells in local draining (inguinal) LN were 
only sl.ightly diminished (about 10%) but were inhibited in their 
prol.iferative response to SEB by more than 60% (Table I) com-
pared to V{38 + T cells of PBS-treated control animals. Mter 2 
weeks of SEB injections, V (38 + T cells were decreased to a greater 
extent (about 30%) and were inlubited even more in their prolif-
erative response to SEB (about 85%, Table 1) . In contrast, V{314 + 
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Table I. Decreased Frequency ofV/38+ T-Cells and Proliferative Responses to SEB of Inguinal LN Cells I11 Vitro After 
Repeated Cutaneous Exposure to SEB Iu Vivo" 
f Prctteatmcnt !11 Vi11o 
Vf3 expression (as %ofT cells) 
Vf38 + 
Vf314 + 
Proliferative response i11 vitro (cpm) 
Medjtm1 
SEB (1 J..tg/ml) 
Con A (5 J..tg/ ml) 
PBS 
32.0 :!: 1.5 
11.9 ± 1.2 
1,168 :!: 231 
31,012 :!: 3,622 
80,900 :!: 9,628 
l Week 
SEB 
27.2 ± 1. "11' 
12.0 ± 1.3 
1,714 :!: 217 
11,398 ± 2,1591' 
72,244 :!: 9,261 
PBS 
33.2 :!: 1.9 
11.6 :!: 1.1 
1 '109 :!: 195 
29,639 :!: 3,516 
74 .889 :!: 8.116 
2 Weeks 
SEB 
24.0 :!: 1.21' 
12.1:!: 1.3 
1,320 ± 248 
4,270 ± 717'' 
65 ,361 :!: 7,852 
a Mice were injected intradcnnally every other day for 1 or 2 weeks with SEB (50 ng in PBS) or PBS. Regional LN cells were prepared and analyzed by flow cytometry as 
described in /v/ntcrials at1d 1\1/etlwtls. The frequen cy ofVJ3-cxpressin gT cells is shown as the mean :!:: SO of five independent experiments. expressed as% ofT cells (CD3 +). Cells 
from the same preparation were also analyzed for thci.r proliferative response to SEB or Con A in 3 d cultures as described in 1\lfatelials am/ J\llt:ilrods. The data (cpm) arc shown as 
the mean :± SO of five independent experiments. 
b Indicates results where the data of SEB-prctTeatcd animals dirfer from PBS-pre treated anJmals significantly (p < 0.05) . 
T cells were not diminished and the proliferative response to Con 
A was only slightly reduced (Table I), indicating the V,B-specificity 
of the inhibitory elfect of SEB in tlus model. 
Modulation of IFN-y Production by SEB In addition to the 
' moderate decrease in frequency ofV,BS + T cells in the inguinal LN 
and the marked inhibition of their proliferative response to SEB 
after 2 weeks ofSEB injections, we observed a marked inhibition of 
IFN-1' production in response to SEB i11 vitro (Table II). Interest-
ingly, IFN-y production in response to SEB i11 11ilm was enhanced 
when regional draining LN cells were collected 24 h after a single 
injection of 50 ng ofSEB. Stimulation with DNFB itself or its water 
soluble counterpart DNBS03 i11 11itro did not yield consistent 
results. 
The inhibition of cell proliferation and TFN--y production by 
V/38 + T cells in response to SEB in 11itro may explain the decrease 
in development of contact sensitivity to DNFB after repeated SEB 
injections. In contrast, interferon-")' production and development of 
contact sensitivity were enhanced following a single injection of 
SEB. 
DISCUSSION 
In this study we demonstrate that treatment with a low concentra-
tion of the superantigen SEB enhances sensitivity to DNFB; in 
contrast, repeated injections over 1-2 weeks inlubits tlus process. 
Enhancement is most likely secondary to the development of local 
inflammation (including infiltration of the skin by T cells and 
expansion ofV,B8 + T cells in the skin associated lymphoid tissues 
Table II. Modulation of IFN-y Production of Inguinal 
LN Cells in Response to SEB Itt Vitro After Cutaneous 
Exposure to SEB I11 Vivo" 
Pretreatment !11 Vil'o 
SED 
Controls SEB Single Repeated 
Stimulation !11 Unttcated Injection Injections 
Vitro (48 h) (pg/ ml) (pg/m l) (pg/ml) 
Medium < 500 < 500 < 500 
SEB (1 J..tg/ml) 2,965 ± 728 10,374:!: 3,511 1' < 5001' 
a One group of mice was treated with repeated intradermal injections ofSEB (50 ng) 
every other day over a period of two weeks, and received the lase injection 24 h before 
sacrificing (re peated injections). A second brroup was injected o nce with SED (50 ng) 
24 h before sacrificing (single injection). The third group was untreated. Inguinal LN 
cells were prep:~rcd and stimulated in ,,;,ro as indicated. After 48 h. ccll-&cc 
supen1atants were harvested and IFN--y was measured as described in Nfatel"ials ami 
Metil otls . The results arc given ;1s mean ± SO of two i.i1dcpcndent experiments. 
b lndic;atcs results where the data of SED-pretreated anim:tls dilfCr from untreated 
animals significantly (p < 0.05) . 
that are involved in contact sensitivity to DNFB). A flare-up of 
reactions at sites where contact dermatitis has been previously 
induced have also been described after systemic application of 
higher amounts of superantigen [24]. One additional augmenting 
elfect may be due to the increase in IFN--y production in regional 
LN cells in response to SEB. The capacity of superantigens 
including SEB for induction of IFN--y and otl1er pro-inflammatory 
cytokines that play a role in contact sensitivity has been described in 
dilferent experimental settings by other investigators [25 ,26]. 
The inlubitory elfects of chronic SEB pretreatment, on the other 
hand, may be explained by the downregulation of V/38 + T cells. 
This outcome would be expected, because tlus subset ofT cells has 
been shown by us to be a major T-cell population that mediates 
contact sensitivity to DNFB in cell transfer experiments. The 
decreased proliferative response to SEB iu vitro may point to the 
induction of anergy in DNFB-reactive V,BS + T cells in the absence 
ofV,B8 + T-cell de letion. The capacity to produce cytokines that are 
in1portant for contact allergy was also reduced, as is demonstrated 
here for IFN--y. Inhibition of SEB-induced IFN--y production i11 
vitro after SEB exposure iu 11i11o has also been reported by other 
investigators [14]. Any differences between individual studies may 
be attributed to dilferences in tl1e route of administration of the 
superantigen and the quantities injected. The inlubitory elfect of 
SEB on the T cells was V,B-specific, as V,BS + T cells (SEB reactive) 
were decreased in frequency and response, whereas V ,1314 + T cells 
were not significantly a.lfected. Moreover, the proliferative re-
sponse to SEB was· inhibited, whereas the response to Con A 
remained intact. Additio~ally, nugration ofV,BS + T cells to sites of 
contact allergen challenge inay be inhibited by downregulation of 
important adhesion molecules after SEB treatment [27]. The lack of 
inhibition of contact sensitivity to DNFB after pretreatment with 
repeated injections of SEA does not exclude the possibility tl;at 
there may be DNFB-specific T cells among SEA-reactive V,B 1, (3), 
10, 11, 12 and (17)-positive T cells [7,24] . It demonstrates, rather, 
that downregulation of these V,B T-cell populations is not sufficie;1t 
to inlubit contact sensitivity to DNFB, as it leaves V,B8 + T-cells, a 
m;Uor T -cell population able to mediate contact sensitivity to 
DNFB, unalfected. 
In addition to binding to V,B elem ents of the T - cell recepto"r. 
superantigens also target MHC class n cell s. The bindu1g of 
superantigens to MHC class Il molecules on antigen-presenting 
cells leads to signalu1g events and secretion of cytokines and may 
alfect their accessory cell function as well [28-30]. Altered general 
accessory cell function appears to be excluded as an explanation for 
the inhibition of induction of contact sensitivity to DNFB by 
chronic SEB exposure, because this function remained intact in LN 
and spleen cells, in view of the normal response to Con A. Whether 
another specialized function of these cells (or a subpopulation of 
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such cells e.g., epide rm:al Langerhan s' cells) is inhibited rem ains to 
be detennined. 
Derm al mast cells are also a:ffected b y exposl! re of the skin to the 
superantigen SEB. In contrast to m o n keys, w here immedi ate type 
skin reactions have bee11 repo rted to be elicited by superantigens 
[31 ) m ast cell degranula tio n in m ice occurs only after a few hours, 
pointing to a rather indirect effect of SEB o n these cells.§ N ever-
the less, m ast cell degran ·u]ation m ay be an additio nal fac tor explain-
ing the m odulatory effect of supe rantigen s o n the development of 
con tact sen si vi ty, expecially the enhan cin g effect of a single injec-
tion of SEB [32,33 ). 
T he inhibitio n of di ffe rent immuno logic phenomen a in vi11o by 
superantigens, including modula tio n o f delayed type hypersensitiv-
ity respo nses (20-23), h as been d escribed by o ther investiga to rs. To 
the best of o ur knowledge, o nly on e report exists con ceming th e 
mod ulation of contact sensitivity by superan tigens. Kawag uchi-
Nagata and coworkers [24] describe d tb e inhibition o f contact 
sensitivity to D N FB by SEA in C5 7BL/6 mice. N o anaJ ysis of V{3 
T - cells m ediating contact sensitiv ity to DN FB in these mice o r 
investigation of changes i.I1 number or function of V {3 T - cell subsets 
was repo rted in this sti.Jdy . 
l n comparison to other studies exploring tbe e ffects o f superan-
tigens on V(3 T - cell sub sets i n 11i110 [1 t -13,34,35] , deletion of V{38+ 
T cells after SEB expos ure w as ra ther limited in our experiments. 
T lu s is likely due to th e local inoc·ul ation of sm all amounts of th e 
superantigen , w hich m:ay closely resemble the physiologic situatio n 
w ith SEE-producing stapltylococci on the skin [18,19] . N evertheless, 
even th ese sm all amot.Ints of superantigen applied loca lly h ad a 
noticeable effect on the skin itself, on the associated lymphoid tissue 
of the skin , an d o n skjn - de rive d imm une responses . In a clinical 
setting, superantigens o f skin-colo niz ing bacteria may thus modu-
late the course of allergic contact derma titis. C hronic exposure o f 
th e skin to staphylococcal enterotoxins as it occurs in atopic 
derm ati tis (1 8, 19Jma y con trib u te to the decrease in contact alle rgic 
responses repo rted to ;'lccompany this skin disorder [36,3 7]. 
T his work wns suppcm ed by DPG grnots Sn 483 n11d K 11 120 n11d N /J-1 grn11ts HL 
36577, AR 4 J256 nud HL 37260. 
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